What is he best known for?
The fields of study he is best known for:
Internal medicine, Endocrinology, Thyrotropin receptor, Receptor and Thyroid are his primary areas of study.
His Internal medicine research incorporates elements of Virus and Antibody.
As a member of one scientific family, Yuji Nagayama mostly works in the field of Endocrinology, focusing on IL-2 receptor and, on occasion, T lymphocyte.
The study incorporates disciplines such as Epitope, Molecular biology, Protein subunit and Biochemistry in addition to Thyrotropin receptor.
His Receptor research is multidisciplinary, incorporating perspectives in Monoclonal antibody, Site-directed mutagenesis and Pathogenesis.
Yuji Nagayama has included themes like Apoptosis, Cancer research and In vitro in his Thyroid study.
His most cited work include:
- Differences and Similarities in the Diagnosis and Treatment of Graves' Disease in Europe, Japan, and The United States (301 citations)
- The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim (179 citations)
- A Novel Murine Model of Graves’ Hyperthyroidism with Intramuscular Injection of Adenovirus Expressing the Thyrotropin Receptor (157 citations)
What are the main themes of his work throughout his whole career to date?
Yuji Nagayama spends much of his time researching Internal medicine, Endocrinology, Thyroid, Immunology and Thyrotropin receptor.
The various areas that Yuji Nagayama examines in his Internal medicine study include Gastroenterology and Antibody.
In Endocrinology, Yuji Nagayama works on issues like IL-2 receptor, which are connected to T lymphocyte.
His research investigates the connection with Thyroid and areas like Cancer research which intersect with concerns in Thyroid carcinoma, Carcinogenesis, Suicide gene, Genetic enhancement and In vivo.
As a part of the same scientific family, Yuji Nagayama mostly works in the field of Immunology, focusing on Graves' disease and, on occasion, Immune tolerance, Euthyroid, Anti-thyroid autoantibodies and BALB/c.
His Thyrotropin receptor research includes elements of Receptor, Biochemistry, Ectodomain, Molecular biology and Epitope.
He most often published in these fields:
- Internal medicine (47.22%)
- Endocrinology (44.44%)
- Thyroid (30.00%)
What were the highlights of his more recent work (between 2012-2020)?
- Thyroid (30.00%)
- Thyroid cancer (10.56%)
- Cancer research (15.00%)
In recent papers he was focusing on the following fields of study:
His main research concerns Thyroid, Thyroid cancer, Cancer research, Internal medicine and Cancer.
His biological study spans a wide range of topics, including Carcinogenesis, Extracellular and Adenoma.
Yuji Nagayama has researched Thyroid cancer in several fields, including Cancer stem cell and Thyroid peroxidase.
His Internal medicine study frequently draws connections to adjacent fields such as Endocrinology.
His research in Endocrinology intersects with topics in Immunohistochemistry, Receptor and Autoimmunity.
His Receptor research includes themes of Graves' disease, Antibody and Immune system.
Between 2012 and 2020, his most popular works were:
- Malfunction of Nuclease ERCC1-XPF Results in Diverse Clinical Manifestations and Causes Cockayne Syndrome, Xeroderma Pigmentosum, and Fanconi Anemia (147 citations)
- Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse (51 citations)
- XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency (34 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Thyroid cancer, Molecular biology, Cancer, Cancer research and Cancer stem cell.
His Thyroid cancer research entails a greater understanding of Thyroid.
He combines subjects such as DNA damage, Genome instability, DNA synthesis, DNA repair and LIG4 with his study of Molecular biology.
In the field of Internal medicine and Endocrinology Yuji Nagayama studies Papillary thyroid cancer.
The concepts of his Internal medicine study are interwoven with issues in Antibody and Immune system.
Yuji Nagayama is involved in the study of Endocrinology that focuses on Graves' disease in particular.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
